Life Science Hotlist

Find selected Life Science companies in Stockholm

The Stockholm-Uppsala Life Science Investment Hotlist features a carefully selected list of investment cases from one of the world’s leading knowledge regions. Curated by Invest Stockholm , the list is a tool for investors focused on disruptive commercial innovation in life science. The hotlist is updated continuously so stay tuned. This project is supported by the European Union.

Please contact us to book a meeting free of charge, to nominate a company to the hotlist or to request a full version (pdf) of the hotlist. 

Category
Sub Category
  • 1080 Motion - provides advanced solutions for functional testing, training and rehabilitation. Used in performance development, sports medicine and research, each tool measure and develop the physical factors of human performance.

  • Abera Bioscience - has developed next-generation bacterial and derived OMV vaccine delivery platforms that combine high-level multivalent antigen presentation with strong stimulation of the immune system.

  • Affibody - is a clinical stage biopharmaceutical company developing a portfolio of innovative drug projects based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

  • AlzeCure Pharma - Develops innovative therapies for the treatment of Alzheimer ́s disease and related neurodegenerative disorders.

  • Athera - is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease.

  • Belly Balance - The digital IBS-treatment in your pocket.

  • BioLamina - Stem cell culturing made easy.

  • Biomedical Bonding - A paradigm shift in bone fracture fixation and restoration.

  • Biovica - creates blood assays for prognosis and monitoring of solid tumors.

  • BlueCall - A digital platform for anonymous therapy counseling, preventing mental health issues in collaboration with employers, insurance companies and health care providers.

  • Bonzun - offers pregnant women and expecting fathers high quality medical information in AI enhanced app, digital health for pregnant women and families.

  • Brighter - Brighter delivers data-driven solutions for smarter treatment of chronic conditions – improving quality of life, easing the burden on healthcare systems and opening new opportunities for data-driven research.

  • Byon8 - has developed, AITOPYA, an unique A.I. platform for medical diagnostic support for physicians and other caregivers, where the patient is in focus and guided to register their health information (Anamnes). The result is a better accuracy in diagnosis and time savings.

  • Camanio Care - a care tech company that develops innovative solutions for an excellent care at home with the individual in focus. Camanio Care offers digital service platforms for digital care, robotics, assistive devices and gamification

  • CareLigo - CareLigo’s home-based mHealth-solution OPTILOGG® is clinically proven to reduce the burden of heart failure by 29 %, and heart failure is the most common cause of hospitalization for people over 65 with 38 million people affected world wide. Having established presence on the Swedish market, the target is now set on internationalization.

  • Cartana - enables researchers from academia and industry to decipher function and disease of the brain and other organs or tumors to much greater depth than previously possible. CARTANA aims to become the number-1-facilitator for finding and validating new treatment strategies against the major diseases.

  • Coala - Coala Life has developed and launched prize-winning, digital solutions enabling daily monitoring and analysis of your heart

  • C-Sense - is a company offering intelligent sensors for a variety of applications. C-sense has developed C-nose, a multi-sensor electronic nose that can be used as a bomb-nose as well as in food control and medical diagnostics.

  • CytaCoat - provides a unique, universal and covalently coupled antibacterial coating for prevention of hospital acquired infections associated with the use of medical devices. The CytaCoat technology is active against several clinically relevant bacterial strains including multi drug resistant bacteria such as MRSA and ESBL.

  • Diamyd Medical - develops therapies using our in-licensed substances GAD and GABA for the prevention or treatment of diabetes and other serious inflammatory diseases.

  • Double Bond Pharmaceutical - develops superior medicines by formulating the best known pharmaceutical compounds to target exactly the diseased organs.

  • DoubleStrand Bioinformatic - is a full service data science and bioinformatics company providing tailored solutions to the Biotech, Healthtech, Medtech and Pharma community. We create value from your data.

  • Empros Pharma - develops EMP16 an oral treatment for obesity and type 2 diabetes. Phase 2a trial demonstrates best-in-class safety profile and promising efficacy by innovative re-formulation of established drugs. Uniquely fast moving, low cost, low risk obesity project invites investors.

  • Encare - enabling ERAS® (Enhanced Recovery After Surgery) for improved quality of care resulting in enhanced patient outcome and more effective healthcare spend.

  • Geras Solution - offers a digital ecosystem of clinically validated tools for individuals impacted with dementia, by providing remote access to specialists for early assessment, risk reduction and disease management support.

  • Glucox Biotech - Identifies and develops selective and specific Nox4 inhibitors with drug like properties.

  • Gradientech - Ultra-rapid sepsis treatment diagnosis - The QuickMIC™ diagnostic system under development generates phenotypic antibiotic susceptibility testing (AST) results from positive blood culture in as little as 2 hours

  • HepaPredict - is a contract research organization (CRO) specializing in drug metabolism and toxicity. We offer in-house evaluations of drug metabolism, pharmacokinetic properties and safety as well as drug target validations based on our novel long-term stable physiological 3D spheroid culture platform.

  • HNRY - improves health care efficiency and patient safety by automating and standardizing medical documentation. This saves time, improves quality and is cost efficient.

  • iCellate - can detect cancer before symptoms occus. It is achieved by capturing the single cells that spread the disease, the Circulating Tumor Cells (CTC).

  • Ilya Pharma - is developing the next generation biological drugs for treating wounds in skin and mucosa.

  • InDex Pharmaceuticals - is a biopharmaceuticals company developing cobitolimod which is in late stage clinical development for ulcerative colitis with a novel mechanism of action that has shown clinical proof of concept, and is safe and well tolerated.

  • Inhalation Sciences Sweden AB - Offers state of the art solutions for pre-clinical aerosol R&D and toxicity testing including aerosol- and exposure characterization, pharmacokinetic testing in vitro and in vivo. With one aerosol source and a variety of modules true in vitro in vivo correlations (IVIVC) can be explored using small amounts powder substances, formulations or solutions.

  • Invicta Medical - is a medical technology company that specializes in innovative therapies for sleep apnea.

  • IsletOne Therapeutics - proprietary clinical-stage off-the-shelf cell therapeutics within inflammation and autoimmunity, combined with an extensive pipeline of promising pre-clinical projects.

  • Lexplore - offers a completely new non-invasive screening method, enabling early, rapid, reliable and objective detection of people at risk of Parkinson’s and Alzheimer’s disease.

  • Linkura - Are on the cutting edge in the movement for democratizing health care. We empower people to improve their wellbeing using state-of-the-art ECG and AI-coaching.

  • Lokon Pharma - developing immunostimulatory gene therapy for cancer using oncolytic viruses.

  • Lyfepond - is a one-stop shop for patients and dependants, where they receive support in their diagnose through qualified patient support programs, contact with industry, other patients and a marketplace for third-party providers of curative, relieving and health promoting products and services. Lyfepond is the first integrator in the fast-growing eHealth market.

  • Mando Group - A consumer version of an evidence based bio feedback device, used successfully to treat eating disorders for twenty years, has proven effective in weight loss.

  • MediCheck - provides people with a shortcut to medical specialists, making better use of society’s medical knowledge and delivering it to more people in need.

  • MediTuner - offers the first clinically validated mobile platform to standardize asthma self-management for patients and healthcare providers.

  • MedUniverse - is a patient case engagement platform offered to the life science industry as cloud-based SaaS, to effectively inform, educate and engage health care professionals about new treatments, therapies, guidelines and devices via digital patient cases and similar content. Aggregated anonymized data from interactions is captured which serves as valuable BI/customer insights presented in visually compelling dashboards with the possibility for further data mining/analysis.

  • Mimerse - creates evidence based automatic psychological treatments in collaboration with leading researchers and hospitals. They are on a mission to solve the world's mental health problem with immersive technologies.

  • MindApps - is developing apps in the area of Mental Health. Has developed the market leading app The Mindfulness App and is about to convert the app to a subscription model. Up till today the app has more than 1 million downloads. Under development is also; “MindGym” a digital platform accessible from smart phones, tablets and computers that offer courses, programs and modules within the area of mindfulness and health in its wider sense

  • Minnity - The Minnity app enables professional caregivers to deliver individualized dementia care to every caretaker with the help of a smartphone.

  • Neodynamics - is a new technology micropulse biopsy system for improved diagnosis of cancer patients.

  • NextCell Pharma - Is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for autoimmune and inflammatory diseases and transplantation. Drug candidate ProTrans, is a stem cell product based on mesenchymal stem cells from umbilical cord tissue with regenerative and immunosuppressive activity

  • Pelago Bioscience - is established to accelerate the use and benefits of the patented CETSA® method in Drug Discovery and Development. Our focus is to deliver physiologically relevant high quality Target Engagement data to customers and collaborators enabling them to develop better and more efficacious new drugs faster.

  • Pilloxa - develops a patient-centric adherence platform. We are currently launching our first product in the form of a smart pillbox with a connected mobile application in order to facilitate medication for the smartphone generation.

  • Prosilico - has developed unique in-silico prediction methodology for ADME/pharmacokinetics (ADME/PK), exposures, doses and optimization of candidate drugs in humans. Prosilico has outperformed lab methods in several internal and external test and placed the company as world-leaders in the field. The superior accuracy and range of this validated computer-based methodology enables reliable predictions at the drug design stage and a reduction of lab studies, uncertainty, time and costs.

  • Qinematic - suite of software enables a gaming sensor to record posture, movement and balance using 3D video. The end user is given instant animated feedback. A health professional can quickly and easily analyze performance, generate reports, for better decision making and monitor progress. Testing is automated and takes just a few minutes.

  • Scandinavian Biopharma - is a Swedish research-based biotech company specialist in marketing and sales of specialty pharma products to the Nordic market and Baltic States. Research and development is mainly focused on development of the first vaccine in the world protecting against diarrhea caused by ETEC in collaboration with PATH Vaccine Solutions and University of Gothenburg

  • SensAbuse - has developed a breath air collection device and system for health monitoring.

  • Senzime - develops unique patient-oriented monitoring systems that make it possible to assess patients’ biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs.

  • Shim - is an evidence-based chatbot that helps users reduce stress and increase emotional well-being. The conversational UI, the low effort required to generate positive emotions and the social aspects makes Shim a better candidate to turn emotional well-being into a true mass market compared to its competitor.

  • Sigrid Therapeutics - has developed a breakthrough medical device, SiPore15, for the treatment of cardiovascular and metabolic risk factors such as elevated blood sugar and blood fat in prediabetic and type 2 diabetic patients.

  • Sinfonia Biotherapeutics - develops novel Bioreactor-delivered treatments for familial & genetically defined neurodegenerative diseases.

  • Single Technologies - develops a technology concept that enables high-resolution 3D videos of molecules, living cells and tissue for proteomic and genetic applications.

  • SinSa Labs - bioengineers Superdrugs to fight the world’s Superbugs.

  • Sprint Bioscience - Sprint Bioscience develops innovative drugs focused on cancer and metabolism.

  • Symcel - Measure life and death of cells and bacteria through direct metabolic readout in label free cell based assays´.

  • Xbrane Biopharma - develops pioneering high demand complex generics with world leading expertise and proprietary high-yield protein expression technology.

  • XSpray - Specializes in optimizing the performance of challenging drug substances with the RightSize technology platform. Focused on improving targeted oral anticancer agents, foremost protein kinase inhibitors.